Alan W Hampson

Summary

Country: Australia

Publications

  1. ncbi Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat
    Alan W Hampson
    Interflu Pty Ltd
    Ann Acad Med Singapore 37:510-7. 2008
  2. ncbi Avian influenza: a pandemic waiting in the wings?
    Alan W Hampson
    Australian Influenza Specialist Group, Monash University, Melbourne, Victoria, Australia
    Emerg Med Australas 18:420-9. 2006
  3. ncbi The influenza viruses
    Alan W Hampson
    Interflu Pty Ltd, Melbourne, Vic, Australia
    Med J Aust 185:S39-43. 2006
  4. ncbi Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy
    Rebecca J Guy
    Department of Human Services, Melbourne, Vic
    Med J Aust 180:640-2. 2004
  5. ncbi Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia
    Aeron C Hurt
    WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
    Commun Dis Intell Q Rep 27:542-7. 2003
  6. ncbi The global circulation of seasonal influenza A (H3N2) viruses
    Colin A Russell
    Department of Zoology, University of Cambridge, Cambridge, UK
    Science 320:340-6. 2008
  7. ncbi Avian influenza and planning for pandemics
    David Isaacs
    Med J Aust 181:62-3. 2004
  8. ncbi Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
    Arnold S Monto
    University of Michigan School of Public Health, Ann Arbor, MI 48109, USA
    Antimicrob Agents Chemother 50:2395-402. 2006
  9. ncbi Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005
    Alan W Hampson
    Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
    Vaccine 24:4897-4900. 2006
  10. ncbi Ferrets and the challenges of H5N1 vaccine formulation
    Alan W Hampson
    J Infect Dis 194:143-5. 2006

Collaborators

Detail Information

Publications14

  1. ncbi Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat
    Alan W Hampson
    Interflu Pty Ltd
    Ann Acad Med Singapore 37:510-7. 2008
    ..New approaches to influenza vaccines which might fulfil the demands of a pandemic situation are under evaluation, however, these remain some distance from clinical reality and face significant regulatory hurdles...
  2. ncbi Avian influenza: a pandemic waiting in the wings?
    Alan W Hampson
    Australian Influenza Specialist Group, Monash University, Melbourne, Victoria, Australia
    Emerg Med Australas 18:420-9. 2006
    ..As a background to these concerns the present article reviews influenza as a human disease, its origins and the involvement of other species, properties of the influenza viruses and the current status of influenza prevention and control...
  3. ncbi The influenza viruses
    Alan W Hampson
    Interflu Pty Ltd, Melbourne, Vic, Australia
    Med J Aust 185:S39-43. 2006
    ..However, during the past 3 years, more than 250 cases of H5N1 infection of humans have occurred, with associated mortality approaching 60%. It is feared that a new pandemic of human influenza may emerge from this...
  4. ncbi Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy
    Rebecca J Guy
    Department of Human Services, Melbourne, Vic
    Med J Aust 180:640-2. 2004
  5. ncbi Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia
    Aeron C Hurt
    WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
    Commun Dis Intell Q Rep 27:542-7. 2003
    ....
  6. ncbi The global circulation of seasonal influenza A (H3N2) viruses
    Colin A Russell
    Department of Zoology, University of Cambridge, Cambridge, UK
    Science 320:340-6. 2008
    ....
  7. ncbi Avian influenza and planning for pandemics
    David Isaacs
    Med J Aust 181:62-3. 2004
  8. ncbi Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
    Arnold S Monto
    University of Michigan School of Public Health, Ann Arbor, MI 48109, USA
    Antimicrob Agents Chemother 50:2395-402. 2006
    ..The frequency of variants with decreased sensitivity to the NAIs did not increase significantly during this period, but continued surveillance is required, especially in regions with higher NAI use...
  9. ncbi Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005
    Alan W Hampson
    Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
    Vaccine 24:4897-4900. 2006
    ..The main conclusions and recommendations from this consultation are presented below...
  10. ncbi Ferrets and the challenges of H5N1 vaccine formulation
    Alan W Hampson
    J Infect Dis 194:143-5. 2006
  11. ncbi Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults
    Ian F Cook
    Discipline of General Practice, School of Medical Practice and Population Health, University of Newcastle, Callaghan, NSW 2308, Australia
    Vaccine 24:2395-402. 2006
    ..Similar results were seen with local adverse effects. These data suggest that vaccination practices that ensure intramuscular injection are required for optimal administration of influenza vaccines in the elderly...
  12. ncbi Concurrent summer influenza and pertussis outbreaks in a nursing home in Sydney, Australia
    Mark J Ferson
    South Eastern Sydney Public Health Unit, Randwick, New South Wales, Australia
    Infect Control Hosp Epidemiol 25:962-6. 2004
    ....
  13. ncbi Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir
    Aeron C Hurt
    WHO Collaborating Centre for Reference and Research on Influenza, 45 Poplar Road, Parkville, VIC 3052, Australia
    Antiviral Res 62:37-45. 2004
    ....
  14. ncbi The epidemiology and clinical impact of pandemic influenza
    Jonathan S Nguyen-Van-Tam
    Aventis Pasteur MSD, Mallards Reach, Bridge Avenue, SL6 1QP, Maidenhead, UK
    Vaccine 21:1762-8. 2003
    ....